ABSTRACT We aimed to quantify the rate of gluconeogenesis (GNG), non-essential amino-acid (NEAA) synthesis, and substrate partitioning to the Krebs cycle in embryonic (e) day e14 and e19 chicken embryos. An in ovo continuous tracer infusion approach was employed to test the hypotheses that GNG and NEAA synthesis in developing chicken embryo increases from e14 to e19. [ 13 C 6 ]Glucose or [ 13 C 3 ]glycerol was continuously infused (8 h) into the chorio-allantoic compartment of eggs on e14 and e19. Glucose entry rate, Cori cycling, and GNG were higher (P < 0.05) in e19 compared to e14 embryos, presumably to support higher glycogen deposition in liver and muscle. Whereas de novo synthesis of alanine, aspartate, and glutamate via glycolysis and the Krebs cycle was higher (P < 0.01) in e14 embryos, synthesis of these NEAA from glycerol was higher (P < 0.05) in e19 compared to e14 embryos. These patterns of glucose and glycerol utilization suggest a metabolic shift to conserve glucose for glycogen synthesis and an increased utilization of yolk glycerol (from triacylglyceride) after e14. Although the contribution of glycerol to GNG in e19 embryos was higher (P < 0.05) than that in e14 embryos, the contribution of glycerol to GNG (1.3 to 6.0%) was minor. Based on [ 13 C 6 ]glucose tracer kinetics, the activities of both pyruvate carboxylase (PC) and pyruvate dehydrogenase (PDH) in the liver were higher (P < 0.05) in e19 embryos; whereas the higher (P < 0.01) relative activity of liver PC compared to PDH in e14 embryos suggests a greater anaplerotic flux into the Krebs cycle. In summary, the in ovo continuous tracer infusion approach allowed for a measurement of chicken embryo whole body and liver metabolism over a shorter window of development. This study provided quantitative estimates of the developmental shifts in substrate utilization, GNG, and NEAA synthesis by chicken embryos, as well as qualitative estimates of the activities of enzymes central to the Krebs cycle, glucose, and fatty acid metabolism.
INTRODUCTION
Metabolism in the chicken embryo between embryonic (e) day 11 to post hatch day 1 undergoes dramatic changes to adjust to different physiological and metabolic demands of growth. As the embryo develops and O 2 diffusion across the air−cell membrane increases, the substrates that the embryo metabolizes for energy must shift from carbohydrates (respiratory quotient, RQ ∼1.0) to fatty acids (RQ ∼0.7) (Rahn et al., 1974; Moran, 2007; De Oliveira et al., 2008) . In a previous study from our lab (Hu et al., 2013) , e14 was found to be a critical time point in embryo development. At this stage, liver adenosine monophosphate ki-nase (AMPK) activity is at its highest, and embryo metabolism differs on e14 in eggs from young compared to old breeders. Others have also shown that from e14 onwards to e19, the rate of embryo development is most dramatic as this period coincides with enhanced oxygen consumption, hormonal changes, and increased storage of muscle glycogen that is likely used to fuel muscle contractions during pipping and emergence (Pearce, 1977; Tazawa et al., 1992; Lu et al., 2007) . Because e14 to e19 is a critical and dynamic period of embryo development, when the initial egg nutrient composition is most likely to influence macronutrient metabolism and, subsequently, embryo growth and survival, we chose to focus on this phase for the current study.
Although carbohydrate content is less than 3% (DM basis) in a typical egg (Romanoff and Romanoff, 1967) , glucose is an essential nutrient for energy supply and brain and immune system function (Humphery and Rudrappa, 2008) . Plasma glucose is detected as early as e4, and increases steadily throughout development (Romanoff and Romanoff, 1967; Hazelwood, 1971, Sunny and Bequette, 2010) . High rates of gluconeogenesis (GNG) and glycogenesis occur after e13 to match the increased demand for glucose (Pearce, 1977; Picardo and Dickson, 1982) . This up-regulation of GNG is crucial in the later term embryo to ensure blood glucose supply for development, and for muscle and liver glycogen deposition. Thus far, the rate of GNG and substrate partition to the Krebs cycle from e14 to e19 has not been well characterized in chicken embryos.
In addition to glucose, non-essential amino acids (NEAA) are also critical during embryonic development. We have previously demonstrated that the embryo synthesizes NEAA (Sunny and Bequette, 2010) , which naturally raises the question "What are the substrates for NEAA synthesis?" Glycerol is a well-known glucogenic substrate which is phosphorylated and subsequently converted to glyceraldehyde phosphate and dihydroxyacetone phosphate in the liver. Thus, glycerol has the potential to contribute to GNG, the pentose phosphate pathway, and Krebs cycle metabolism via the 3-carbon pool. [ 13 C 3 ] glycerol has been used to quantify the contribution of glycerol to glucose synthesis in healthy term and preterm infants (Sunehag et al., 1996a,b) as well as the rate of whole body lipolysis (Bilz et al., 1999; Hickner et al., 1999 ). Yet the contribution of glycerol to NEAA synthesis in chicken embryos during e14 and e19 is unknown.
Previously in our lab, a daily injection protocol was employed for dosing stable isotope tracers into the chorio-allantoic compartment of developing eggs to quantify the glucose, glycogen, and NEAA metabolism Bequette, 2010, 2011) . Although steadystate labeling was often achieved, the method was timeconsuming (3 to 4 days of dosing), embryo losses were common, and there were large variations in the enrichment of dosed tracer in the blood that the contribution of glycerol to glucose synthesis could not be determined in that study (Sunny and Bequette, 2011) . To minimize variation and shorten the period of tracer administration to investigate a smaller window of embryo development, a constant tracer infusion protocol was developed (8-h infusion) in the current study to promote steady-state labeling of intermediates and improve the accuracy of estimating GNG, NEAA synthesis, and substrate partitioning in developing chicken embryos.
MATERIALS AND METHODS

Egg Incubation and Stable Isotope Tracer Infusion
The experiment protocol described herein was approved by the University of Maryland Institutional Animal Care and Use Committee. Fertile eggs (61.2 ± 3.2 g, n = 51) from layers (∼50 wk old, White Leghorn) were acquired from B & E eggs (York Springs, PA). Eggs were incubated at 37.5
• C, under the standard conditions of 65% relative humidity. On e9, eggs were candled and undeveloped eggs removed. A tracer infusion protocol was developed for continuous infusion of 
Sample Collection and Analysis
At the end of infusion, a hole was made into the large end of the egg with scissors, the crown removed, and whole egg contents were carefully transferred to a Petri dish placed on ice after removing the infusion line. The vitelline vessels (artery and vein) were exposed and blood was collected into a 0.5 mL syringe equipped with a 27-gauge needle. Blood was transferred to a 1 mL blood collection tube (Multivette, Sarstedt AG & Co, Nuembrecht, Germany) with a solid lithium heparin ring to prevent blood clotting and immediately frozen at −20
• C. Embryo fresh weight was recorded, and the whole liver was dissected and wrapped in aluminum foil before being plunged into liquid nitrogen.
Glucose and Amino Acid Enrichment
Glucose in blood (50 μL) was extracted with 0.5 mL of ice-cold methanol, vortex mixed and centrifuged for 10 min at 13,000 g at room temperature. The supernatant was applied to cation-exchange resin (AG 50W-X8 resin, 100-200 mesh; Bio-Rad Laboratories, Hercules, CA), and glucose was eluted from the resin with 2 mL of dH 2 O, frozen, and lyophilized to dryness. Glucose was converted to the di-O-isopropylidene acetate derivative (Hachey et al., 1999) prior to gas chromatography-mass spectrometry (GC-MS). After separation by GC (ZB-50; 30 m × 0.25 mm× 0.50 μm, Phenomenex, Torrance, CA), selective ion monitoring of ions with mass-to-charge (m/z) 287 to 293 was recorded by MS (5973 N Mass Selective Detector coupled to a 6890 Series GC System, Agilent, Palo Alto, CA) under electron ionization conditions (Sunny and Bequette, 2010) . For determination of NEAA enrichments, liver samples (60 mg) were deproteinized by addition of ice-cold 10% sulpho-salicylic acid (w/v) and homogenized on ice. The homogenates were centrifuged for 10 min at 13, 000 g at room temperature, and the acid supernatant was applied to cationexchange resin (AG 50W-X8 resin, 100-200 mesh; Bio-Rad Laboratories). Amino acids were eluted from the resin with 2 mL of 2 M NH 4 OH followed by 1 mL of dH 2 O. The eluate was frozen and lyophilized to dryness. Amino acids were derivatized with a mixture of Nmethyl-N-[tert-butyldimethyl-silyl]trifluoroacetimide containing 1% tert-butyldimethylchlorosilane and dimethylformamide (v/v, 1:1) (Agarwal et al., 2015) . After being heated by microwave (200 W for 2 min), the amino acid t-BDMS derivatives were separated by GC (ZB-50; 30 m × 0.25 mm × 0.50 μm, Phenomenex, Torrance, CA) and the MS operated in electron ionization mode. The following ions of m/z were monitored: alanine 260, 263, aspartate 418, 422, and glutamate 432, 437. The fragment ions monitored (e.g., 263 for alanine) contained all carbons for that amino acid.
Glycerol Enrichment
Glycerol in blood (50 μL) was extracted with 0.5 mL of ice-cold methanol, vigorously vortexed, and centrifuged at 13,000 g for 10 min. The extract was dried under N 2 gas, and glycerol was converted to the triacetate derivative by addition of acetic anhydride and pyridine (v/v, 2:1) and heated at 60
• C for 30 min. Next, the sample was reduced to dryness under N 2 gas and reconstituted in ethyl acetate (100 μL) prior to GC-MS analysis. Glycerol triacetate was separated by GC (HP-5; 30 m × 0.25 mm × 0.25 μm, Hewlett-Packard, Palo Alto, CA) with helium as the carrier gas. The MS was operated in methane positive chemical ionization mode, and ions of m/z 159 to 163 were monitored for glycerol enrichment (Kalhan et al., 2001) .
Calculations
Due to sampling limitation and technical difficulties, data from 6 replicates each in e14 and e19 embryos in Exp. 1 and data from 5 replicates each in e14 and e19 embryos in Exp. 2 were validated and utilized for the final calculations. Throughout this paper, isotopomers of glucose, glycerol, and NEAA containing 1, 2, 3,. . . n 13 C atoms are denoted as M1, M2, M3, . . . Mn. The crude ion abundances of analytes were corrected for the natural abundance of isotopes (i.e., 13 C, 2 H, 15 N, and O 17/18 ) present in the molecule and in the derivative employing a matrix approach (Fernandez et al., 1996) . Natural isotopomer distributions in unlabeled glucose, glycerol, and NEAA were quantified using unlabeled pure standards. Corrected enrichments of precursors, intermediates and products are reported as moles of tracer [Mn] per 100 moles of tracee [M0] for all calculations.
Glucose Fluxes Calculation of glucose entry rate, recycling (Cori cycle), and GNG were based on the dilution of [M6]glucose (Katz et al., 1989 ) and 13 C-isotopomer recycling derived from glycolytic metabolism of [ 13 C 6 ] glucose Katz, 1996, 1997) . For the calculation of GNG, we made the assumption that glucose synthesis via pyruvate results in 13 C recycling to glucose (Wykes et al., 1998) . The isotope enrichment of alanine, aspartate, and glutamate was calculated to reflect corresponding transamination partners of pyruvate, oxaloacetate, and α-ketoglutarate enrichment (Berthold et al., 1994) .
Apparent Glucose Entry Rate (GER) was calculated according to Wykes et al. (1998) as follows:
where P is the isotopic purity of [ 13 C 6 ]glucose tracer (93.7%).
Glucose carbon 13 C recycling was calculated according to Pascual et al. (1997) :
Estimation of Cori cycling was based on the determination of glucose molecule recycling and calculated as:
Eq. 3 is the fraction of labeled glucose molecules that result from carbon recycling (i.e., Cori cycling) without consideration of the dilution of unlabeled molecules arising from the entry of amino acid and fatty acid carbons into 3-carbon and the Krebs cycle intermediate pools for GNG (Tayek and Katz, 1996) . Thus, Cori cycle flux is calculated as:
and GNG is estimated as: (Berthold et al., 1994 (Berthold et al., 1994; Wykes et al., 1998 (Kalderon et al., 1989; Katz et al., 1989; Lee et al., 1991) . The equilibrium factor approximated to 0.28 (SEM = 0.03) for e14 embryos and 0.30 (SEM = 0.03) for e19 embryos, and did not differ with embryonic age (data not shown).
The fractional contribution of glucose to alanine or aspartate fluxes was calculated as:
The contribution of glucose to glutamate synthesis via oxalacetate was calculated as:
Pyruvate carboxylase and pyruvate dehydrogenase activities were estimated as described below:
[M2]acetyl-CoA enrichment in Eq. 9 was calculated according to Berthold et al. (1994) :
The relative activity of PC versus PDH was estimated as:
Glycerol Fluxes Glycerol entry rate, a reflection of the rate of lipolysis (mostly yolk lipids), was calculated as:
where P is the isotopic purity (96.6%) of the [ 13 C 3 ]glycerol tracer, and G is glycerol enrichment:
The fractional contribution of glycerol to GNG was estimated as:
[M3] glucose/Eq.13
Blood glycerol derived from lipolysis is almost exclusively taken up by the liver for GNG and metabolism (Magnuson et al., 2003; Rui, 2014 
Statistical Analysis
All data were verified to meet assumptions of normality and homogeneity of variance. Results were analyzed by Student t test procedure of SAS 9.2 (SAS Institute Inc., Cary, NC). Results are presented as mean ± SEM. A probability of P ≤ 0.05 was considered statistically significant.
RESULTS
Embryo Growth
For both experiments, the initial egg weight for e14 and e19 embryos did not differ (Tables 1 and 2 ). Body weight of e19 embryos was 200 to 237% higher (P < 0.0001) than that of e14 embryos. 19.7 ± 6.6
Glucose Metabolism
3.9 ± 1.2
15.1 ± 5.3
1.6 ± 0.8 4.6 ± 1.6 age effect P < 0.001 P = 0.042
Values are means ± SD (n = 6).
substantially higher (P < 0.05) in e14 than those of e19 embryos ( Table 1 . For this calculation, both blood and liver glucose enrichments were considered as precursors. Apparent glucose entry rate based on blood and liver enrichment was higher (P < 0.05) in e19 than in e14 embryos, except for BW-adjusted glucose entry rate when blood glucose was selected as the precursor pool and where fluxes did not differ. Fluxes of Cori cycling and GNG (non-Cori cycling) on an absolute basis were higher (P < 0.05) in e19 embryos for both precursor pool selections. When adjusted to a BW-basis, liver Cori cycling increased (P < 0.05) as the embryo developed. These two fluxes on a BW-adjusted basis were not different between e14 and e19 embryos in either blood or liver glucose precursor pool.
In Exp. 2 when [ 13 C 3 ]glycerol was infused, glycerol entry rate adjusted to BW tended to be higher (P = 0.061) in e14 (453 mg per 100 g BW · d
−1 ) than in e19 (111 mg per 100 g BW · d
−1 ) embryos (Table 2) . Although the fractional contribution of glycerol to GNG was higher (P < 0.05) in e19 compared to e14 embryos when blood glucose was considered as the product pool. Overall, the contribution of glycerol to GNG in e19 embryos averaged 2.1% when calculated using blood glucose as the product pool. alanine, aspartate, and glutamate in the liver free pool in e14 embryos were markedly higher (P < 0.01) compared to the corresponding enrichment of e19 embryos (Figure 1a, b, c) . The contribution of blood glucose to liver alanine, aspartate, and glutamate synthesis was higher (P < 0.05) in e14 versus e19 embryos (Figure 2a) .
Glucose and Glycerol Contribution to
When [ 13 C 3 ]glycerol was infused (Exp. 2), estimate of the contribution of blood glycerol to liver alanine and glutamate synthesis was higher (P < 0.05) in e19 embryos than in e14 embryos (Figure 2b ). Blood glycerol contribution to liver aspartate synthesis was not different due to high variation among samples. Compared to other 3-carbon substrates (10 to 50%), i.e., lactate and alanine in the blood (data not shown), the 6.9 ± 3.3 9.1 ± 4.0 3.2 ± 1.6 16.7 ± 8.7 34.5 ± 15.7 134.8 ± 51.5 27.6 ± 12.8 53.6 ± 15.8 age effect P = 0.059 P = 0.029 P = 0.005 P = 0.021 P = 0.016 P = 0.010 P = 0.443 P = 0.483 Liver glucose e14 12.9 ± 4.3 18.3 ± 6.3 8.5 ± 3.3 14.9 ± 9.3 39.6 ± 13.7 54.5 ± 21.0 47.3 ± 8.4 73.6 ± 7.0 e19 2.7 ± 1.1 3.7± 1.6 1.2 ± 0.6 2.1 ± 1.3 7.6 ± 3.2 9.7 ± 3.9 54.6 ± 8.5 79.5 ± 6.7 age effect P < 0.001 P < 0.001 P < 0.001 P = 0.008
1 Values are moles of tracer/100 moles of tracee (means ± SD, n = 6).
contribution of glycerol (0.1 to 0.2%) to glutamate synthesis was much less.
Synthesis of Acetyl-CoA from the 3-Carbon Pool
When [ 13 C 6 ]glucose was infused, the calculated enrichment of liver [M2]acetyl-CoA was higher (P < 0.05) in e14 versus e19 embryos (Figure 3 ). This suggests that glucose contributed more, or that other substrates (e.g., fatty acids, leucine, and lysine) contributed less to acetyl-CoA flux and, thus, less Krebs cycle oxidation in e14 embryos. Unfortunately, limited number of replicates due to technical difficulties precluded statistical evaluation of the contribution of 3-carbon pool to acetyl-CoA synthesis. Despite this limitation, the contribution of blood lactate to acetyl-CoA synthesis was numerically similar in e14 and e19 embryos (16% vs. 17%, data not shown). When blood alanine was considered as the 3-carbon pool precursor, the contribution of alanine to acetyl-CoA synthesis was numerically higher in e14 compared to e19 embryos (42% vs. 36%, data not shown).
In Exp. 2, when [ 13 C 3 ]glycerol was infused, liver [M2]acetyl-CoA enrichment was higher (P < 0.05) in e19 embryos than e14 embryos (Figure 3) 
PC and PDH Activity
The activities of PC and PDH largely determine the anaplerotic flux of 3-carbon pool substrates into the Krebs cycle and into the acetyl-CoA pool for oxidation or fatty acid synthesis. PC activity increased (P < 0.05) from e14 to e19 in embryos (Figure 4a ), suggesting increased anaplerosis in the liver of e19 embryos for GNG, NEAA synthesis, or both. PDH activity was higher in e19 compared to e14 embryos (P < 0.05) indicating more acetyl-CoA was produced from 3-carbon substrates in e19 embryos. The ratio of PC to PDH activity reflects the balancing of 3-carbon pool fluxes into the Krebs cycle for anaplerosis versus oxidation and fatty acid synthesis. In e14 embryos, the ratio of PC to PDH activity was higher (P < 0.05) compared to e19 embryos (Figure 4b ). When [ 13 C 3 ]glycerol was infused, liver PC activity of e14 embryos did not differ from that of e19 embryos. Moreover, the crude ratio of PC to PDH activity did not differ in e14 compared to e19 embryos (0.23 vs. 0.36, data not shown).
DISCUSSION
In the present study, an in ovo continuous infusion approach was employed for delivery of stable isotope tracers into the embryo for quantification of GNG, NEAA synthesis, and substrate partitioning and utilization by e14 and e19 chicken embryos. We hypothesized that GNG and NEAA synthesis increases from e14 to e19. In support of our hypothesis, GNG (non-Cori cycle flux) was higher during e19 compared to e14 embryos, presumably to support higher glycogen deposition in liver and muscle. Contrary to our hypothesis, de novo synthesis of alanine, aspartate, and glutamate via glycolysis was higher in e14 embryos, whereas de novo synthesis of these NEAA from glycerol was higher in e19 embryos. These patterns of glucose and glycerol utilization in the liver suggested a metabolic shift to conserve glucose for glycogen synthesis and an increased utilization of yolk glycerol (from triacylglyceride) after e14. Based on [ 13 C 6 ]glucose tracer kinetics, the activities of both PC and PDH in the liver were higher in e19 embryos and the relative higher activity of liver PC compared to PDH in e14 embryos suggests a greater anaplerotic flux into the Krebs cycle. This study provided quantitative estimates of the developmental shifts in GNG, NEAA synthesis, and substrate utilization by chicken embryos, as well as qualitative estimates of the activity of enzymes central to the Krebs cycle, and glucose and fatty acid metabolism.
The weights of e19 chicken embryos differed remarkably from e14 embryos, featuring a 2-fold increase in both experiments. Based on previous experiments (Hu et al., 2013) , we specifically selected the period between e14 and e19 because e14 is a critical developmental age when we observed enhancement of the energy-sensing modulator AMPK activity and embryo metabolism (e14 and e20) and nutrient content also differed between small and large eggs. The period between these two developmental ages represents the most dynamic period of embryo metabolism and hormonal changes (Wise and Frye, 1973; Savon et al., 1993; Moran, 2007) and the most rapid rate of embryo growth.
[ 13 C 6 ]Glucose and [ 13 C 3 ]glycerol were constantly delivered into the chorio-allantoic compartment of the eggs for three reasons. Firstly, it was technically challenging to insert a catheter into the vitelline or other vessels of the embryo without causing hemorrhage. Secondly, direct uptake of the infused tracers into the blood circulation was possible because of the extensive capillary network surrounding the embryo at these stages. And, lastly, the tracers were infused at a constant, but very slow rate, during 8 h compared to the previous approach of daily bolus dosing of tracers in the laboratory. By the end of the constant infusion period, about 50 mg of tracer was delivered into the eggs and this is less likely to have caused a substrate response by the embryo compared to the single daily dosing approach. This amount was infused to ensure high rates of 13 C incorporation into intermediates and products, and thus not only more accurate estimation of substrate fluxes but also greater distribution of 13 C in downstream pathways to allow for a more global assessment of pathway fluxes and enzyme activities. When [ 13 C 6 ]glucose was infused (Exp. 1), both blood and liver [M3]and [M6]glucose enrichments were lower in e19 embryos. This suggests an increased synthesis of glucose from other sources (i.e., unlabeled intermediates), which resulted in higher dilution of [M3] and [M6]glucose enrichment. Higher glucose entry and greater Cori cycling and GNG on both absolute (blood and liver precursor pools) and BW (liver precursor pool)-adjusted basis were observed in e19 compared to e14 embryos. This pattern of change in GNG is consistent with known changes in corticosterone, an activator of GNG. In the study of Scott et al. (1981) , corticosterone increased rapidly from e10 to e14 until e16, and remained at a higher level through e18, with a tendency to increase up to e20. Further, the ratio of insulin to glucagon also increases during this period, which serves to promote the deposition of glucose into tissue glycogen (Lu et al., 2007) . In consequence, higher GNG in later developmental age leads to greater supply of glucose for glycogen accumulation in the liver and muscles. These observations are also in agreement with our earlier study (Hu et al., 2013) where AMPK activity was highest on e14. Higher AMPK activity is expected to reduce the activity of energy consuming pathways, e.g., GNG, while enhancing energy generating pathways. Moreover, the increased glucose entry rate on an absolute basis also suggested more glucose and glycogen synthesis as embryo weight increased.
In Exp. 2, when eggs were infused with [ 13 C 3 ]glycerol, a higher contribution of glycerol to GNG was observed in e19 compared to e14 embryos. The appearance of 13 C from glycerol in glucose has been used to estimate the contribution of glycerol to GNG (Kalhan and Parimi, 2000) . However, current estimates of the contribution of glycerol to glucose synthesis are variable. Studies in healthy term infants during the first 48 h after birth found that the contribution of glycerol accounted for 10 to 20% of glucose synthesized (Bougnères et al., 1982; Patel and Kalhan, 1992; Sunehag et al., 1999) . In extremely preterm infants on the first day after birth, GNG from glycerol was much lower and ranged from 1.7 to 37.6%, with a median value of 5% (Sunehag et al., 1996a). The e19 chicken embryo might be considered to be at a similar physiological state as the preterm infant. In this respect, the finding in the e19 chicken embryo that glycerol contributes only 2.1% (1.3 to 6.0%) to GNG would appear to be consistent with that of the preterm infant. In addition, these results further demonstrate that other substrates, such as amino acids and lactate, make a more substantial contribution to GNG at this stage of embryo development. In young and adult mice, glucose is an important contributor to NEAA synthesis (Pascual et al., 1998) . Metabolism of glucose leads to significant distribution of its carbon skeletons throughout the glycolytic pathway and in the Krebs cycle where glucose carbon is used for NEAA synthesis. In the estimate of blood glucose to liver NEAA synthesis in Exp. 1, the contribution of glucose to alanine, aspartate and glutamate synthesis decreased as the embryo developed. Although the proportional contribution of glucose to NEAA synthesis was similar to another study (Sunny and Bequette, 2010) , this observation is not consistent with our original hypothesis that NEAA synthesis would be promoted as the embryo grows. The possible explanation is that by e14, the embryo is structurally completed (Moran, 2007) . The embryos require a large amount of amino acids for tissue protein synthesis whereas by e19, embryo protein mass reaches the maximum. More NEAA for protein synthesis would be demanded for the rapid growth of e14 embryos. The higher contribution of blood glucose to NEAA synthesis in e14 embryos may demonstrate that glucose was spared for glycogen accumulation in e19 embryos. In fact, the isotopic profiles of [M1], [M2], and [M3]alanine, aspartate and glutamate in liver also indicated a higher incorporation of glucose carbon by e14 embryos.
In Exp. 2, when [ 13 C 3 ]glycerol was infused, the proportion of alanine, aspartate, and glutamate derived from the 3-carbon pool was smaller compared to Exp. 1. The contribution of glycerol to alanine, aspartate and glutamate synthesis was higher in e19 versus e14 embryos. A higher contribution of glycerol to glucose synthesis was also observed in e19 embryos. One explanation is that on e14, when there is a larger energy requirement for embryo development, glycerol liberated from yolk triglycerides is metabolized in the Krebs cycle to produce energy. The ratio of PC to PDH activity was higher in e14 embryos when the estimation was performed by glucose tracer. Lower activity of PDH in e14 embryos indicated less production of acetyl-CoA from 3-carbon substrates. Therefore, the acetyl-CoA pool must derive from other sources, such as via fatty acid β-oxidation. The latter conclusion is consistent with calorimetric measurements of developing chicken embryos. Hamidu et al. (2007) measured RQ of developing eggs and observed the value to be lower for e14 compared to e19 embryos (0.67 vs 0.71).
In summary, higher glucose entry rate, Cori cycling, and GNG were observed in e19 compared to e14 embryos. The contribution of glucose to NEAA synthesis was higher in e14 than in e19 embryos. These metabolic shifts are consistent with the rapid development of embryos at e14 and the high demand for glycogen accumulation in e19 embryos. The higher rate of lipolysis (glycerol turnover) and contribution of glycerol to both GNG and NEAA synthesis in e19 embryos indicates that glycerol is an important anaplerotic substrate in the Krebs cycle at this stage. The two metabolic probes employed in this study provided information about the developmental adaptations in GNG, the Krebs cycle and activities of related pathways. Results based on [ 13 C 6 ]glucose infusion highlighted the importance of glucose carbon recycling and the utilization of several substrates that contribute to 3-carbon precursor pool for synthesis of NEAA and acetyl-CoA. The results based on [ 13 C 3 ]glycerol infusion provide strong evidence of the changing role of lipolysis in provision of fatty acids for energy, and the utilization of triglyceride derived glycerol for GNG and NEAA synthesis. The constant in ovo tracer infusion protocol developed in this study is also valuable for investigating other aspects of embryo metabolism and pathway activities. The fundamental information gained from the present study regarding glucose metabolism, gluconeogenesis, NEAA synthesis, and the Krebs cycle substrate partitioning in developing chicken embryos allows for a better understanding of the nutrient metabolism through central pathways during this critical transition period. The study of later developmental stage is particularly important for determination of the nutrient supply for an optimal growth post-hatch, as the hatchlings experienced a dramatic nutrient environment change, from an egg nutrient of less than 3% carbohydrate (DM basis) and 45% lipids during the embryo development to a feed composition of greater than 30% carbohydrate and 6% fat post-hatch.
